{"sourcedb":"DevicePMAs@therightstef","sourceid":"P000011_S004","text":"Approval for the biodivysio oc otw in 11 mm, 15 mm, 18 mm, 22 mm and 28 mm stent lengths and 3.0 mm, 3.5 mm and 4.0 mm diameters.  The device, as modified, will be marketed under the trade name biodivysio oc otw and is indicated for:  \"use in subjects with symptomatic ischemic heart disease due to de novo native coronary artery lesions (length \u003C= 25 mm) with a reference vessel diameter ranging from \u003E= 3.0 mm to \u003C= 4.0 mm and intended to improve coronary luminal diameter.  Long-term outcome (beyond 6 months) for this implant is unknown at present.\"","project":"consensus_PMA_Age_Indications"}